Variant report

Variant	esv1844969
Chromosome Location	chr5:106311248-106326299
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:98)
CpG islands
(count:61)
Chromatin interactive
region (count:0)
LncRNA
region (count:5)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:98 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr5:106320004-106320377	H1-hESC	embryonic stem cell:	n/a	n/a
2	ATF2	chr5:106314497-106314745	H1-hESC	embryonic stem cell:	n/a	n/a
3	CHD1	chr5:106319972-106320916	H1-hESC	embryonic stem cell:	n/a	n/a
4	CHD1	chr5:106315310-106316217	H1-hESC	embryonic stem cell:	n/a	n/a
5	CHD2	chr5:106319848-106320228	H1-hESC	embryonic stem cell:	n/a	n/a
6	E2F4	chr5:106322912-106322927	MCF10A-Er-Src	breast:	n/a	n/a
7	E2F4	chr5:106311408-106311424	MCF10A-Er-Src	breast:	n/a	n/a
8	FOS	chr5:106313773-106314013	HUVEC	blood vessel:	n/a	n/a
9	FOXA2	chr5:106318652-106319129	A549	lung:	n/a	n/a
10	FOXA2	chr5:106318624-106318977	A549	lung:	n/a	n/a
11	GATA3	chr5:106323258-106323334	SH-SY5Y	brain:	n/a	n/a
12	GTF2F1	chr5:106314605-106314633	H1-hESC	embryonic stem cell:	n/a	n/a
13	JUN	chr5:106322626-106322657	H1-hESC	embryonic stem cell:	n/a	n/a
14	MAFF	chr5:106324534-106324788	HepG2	liver:	n/a	chr5:106324640-106324658
15	MAFK	chr5:106324547-106324782	IMR90	lung:	n/a	chr5:106324644-106324658 chr5:106324641-106324656 chr5:106324646-106324657 chr5:106324641-106324657 chr5:106324645-106324656 chr5:106324646-106324657
16	MAFK	chr5:106324495-106324776	HepG2	liver:	n/a	chr5:106324644-106324658 chr5:106324641-106324656 chr5:106324646-106324657 chr5:106324641-106324657 chr5:106324645-106324656 chr5:106324646-106324657
17	MAFK	chr5:106321758-106322125	H1-hESC	embryonic stem cell:	n/a	n/a
18	MAFK	chr5:106324583-106324641	H1-hESC	embryonic stem cell:	n/a	n/a
19	MAFK	chr5:106324479-106324812	HepG2	liver:	n/a	chr5:106324644-106324658 chr5:106324641-106324656 chr5:106324646-106324657 chr5:106324641-106324657 chr5:106324645-106324656 chr5:106324646-106324657
20	MXI1	chr5:106321227-106321277	K562	blood:	n/a	n/a
21	POLR2A	chr5:106319249-106319776	H1-hESC	embryonic stem cell:	n/a	n/a
22	POLR2A	chr5:106315170-106315258	H1-hESC	embryonic stem cell:	n/a	n/a
23	POLR2A	chr5:106314964-106316010	H1-hESC	embryonic stem cell:	n/a	n/a
24	POLR2A	chr5:106314083-106315094	H1-hESC	embryonic stem cell:	n/a	n/a
25	POLR2A	chr5:106321472-106322432	H1-hESC	embryonic stem cell:	n/a	n/a
26	POLR2A	chr5:106323046-106323300	H1-hESC	embryonic stem cell:	n/a	n/a
27	POLR2A	chr5:106316856-106317011	H1-hESC	embryonic stem cell:	n/a	n/a
28	POLR2A	chr5:106317829-106318026	H1-hESC	embryonic stem cell:	n/a	n/a
29	POLR2A	chr5:106322894-106325494	H1-hESC	embryonic stem cell:	n/a	n/a
30	POLR2A	chr5:106314240-106314374	H1-hESC	embryonic stem cell:	n/a	n/a
31	POLR2A	chr5:106316177-106317024	H1-hESC	embryonic stem cell:	n/a	n/a
32	POLR2A	chr5:106319000-106321470	H1-hESC	embryonic stem cell:	n/a	n/a
33	POLR2A	chr5:106315263-106316055	H1-hESC	embryonic stem cell:	n/a	n/a
34	POLR2A	chr5:106314215-106314379	H1-hESC	embryonic stem cell:	n/a	n/a
35	POLR2A	chr5:106316799-106317052	H1-hESC	embryonic stem cell:	n/a	n/a
36	POLR2A	chr5:106319961-106320351	H1-hESC	embryonic stem cell:	n/a	n/a
37	POLR2A	chr5:106314289-106314299	H1-hESC	embryonic stem cell:	n/a	n/a
38	POLR2A	chr5:106319298-106319503	H1-hESC	embryonic stem cell:	n/a	n/a
39	POLR2A	chr5:106322124-106322508	H1-hESC	embryonic stem cell:	n/a	n/a
40	POLR2A	chr5:106320969-106321234	H1-hESC	embryonic stem cell:	n/a	n/a
41	POLR2A	chr5:106314402-106314809	H1-hESC	embryonic stem cell:	n/a	n/a
42	POLR2A	chr5:106316364-106316688	H1-hESC	embryonic stem cell:	n/a	n/a
43	POLR2A	chr5:106322594-106322596	H1-hESC	embryonic stem cell:	n/a	n/a
44	POLR2A	chr5:106316221-106316291	A549	lung:	n/a	n/a
45	POLR2A	chr5:106314310-106314962	H1-hESC	embryonic stem cell:	n/a	n/a
46	POLR2A	chr5:106322135-106322333	H1-hESC	embryonic stem cell:	n/a	n/a
47	POLR2A	chr5:106314981-106315178	H1-hESC	embryonic stem cell:	n/a	n/a
48	POLR2A	chr5:106316197-106316388	A549	lung:	n/a	n/a
49	POLR2A	chr5:106316204-106316326	Hela-S3	cervix:	n/a	n/a
50	POLR2A	chr5:106319533-106320498	H1-hESC	embryonic stem cell:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:106312235-106312285	RPTEC	kidney:	n/a
2	chr5:106312235-106312285	NH-A	brain:	n/a
3	chr5:106312235-106312285	NHDF-neo	bronchial:	n/a
4	chr5:106312235-106312285	K562	blood:	n/a
5	chr5:106312235-106312285	HEEpiC	esophagus:	n/a
6	chr5:106312235-106312285	Jurkat	blood:	n/a
7	chr5:106312235-106312285	AG04449	skin:	fetal
8	chr5:106312235-106312285	NB4	blood:	n/a
9	chr5:106312235-106312285	HepG2	liver:	n/a
10	chr5:106312235-106312285	U87	brain:	n/a
11	chr5:106312235-106312285	BJ	skin:	n/a
12	chr5:106312235-106312285	PFSK-1	brain:	n/a
13	chr5:106312235-106312285	ECC-1	luminal epithelium:	n/a
14	chr5:106312235-106312285	HAEpiC	amniotic membrane:	n/a
15	chr5:106312235-106312285	GM12878	blood:	n/a
16	chr5:106312235-106312285	HIPEpiC	eye:	n/a
17	chr5:106312235-106312285	HRE	kidney:	n/a
18	chr5:106312235-106312285	Hela-S3	cervix:	n/a
19	chr5:106312235-106312285	HCT-116	colon:	n/a
20	chr5:106312235-106312285	PrEC	prostate:	n/a
21	chr5:106312235-106312285	GM12891	blood:	n/a
22	chr5:106312235-106312285	AG09319	gingival:	n/a
23	chr5:106312235-106312285	HPAEpiC	pulmonary alveolar:	n/a
24	chr5:106312235-106312285	HEK293	kidney:	embryo
25	chr5:106312235-106312285	A549	lung:	n/a
26	chr5:106312235-106312285	SK-N-MC	brain:	n/a
27	chr5:106312235-106312285	HL-60	blood:	n/a
28	chr5:106312235-106312285	HRPEpiC	eye:	n/a
29	chr5:106312235-106312285	AG04450	lung:	fetal
30	chr5:106312235-106312285	AG09309	skin:	n/a
31	chr5:106312235-106312285	HCF	heart:	n/a
32	chr5:106312235-106312285	HUVEC	blood vessel:	n/a
33	chr5:106312235-106312285	AG10803	skin:	n/a
34	chr5:106312235-106312285	T-47D	breast:	n/a
35	chr5:106312235-106312285	SAEC	small airway:	n/a
36	chr5:106312235-106312285	GM19239	blood:	n/a
37	chr5:106312235-106312285	CMK	blood:	n/a
38	chr5:106312235-106312285	NT2-D1	testis:	n/a
39	chr5:106312235-106312285	ovcar-3	ovarian:	n/a
40	chr5:106312235-106312285	H1-hESC	embryonic stem cell:	embryo
41	chr5:106312235-106312285	GM12892	blood:	n/a
42	chr5:106312235-106312285	ProgFib	skin:	n/a
43	chr5:106312235-106312285	LNCaP	prostate:	n/a
44	chr5:106312235-106312285	IMR90	lung:	fetal
45	chr5:106312235-106312285	PANC-1	pancreas:	n/a
46	chr5:106312235-106312285	MCF-7	breast:	n/a
47	chr5:106312235-106312285	SK-N-SH_RA	brain:	n/a
48	chr5:106312235-106312285	AoSMC	blood vessel:	n/a
49	chr5:106312235-106312285	Caco-2	colon:	n/a
50	chr5:106312235-106312285	Hepatocyte	liver:	n/a

No data

(count:5 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-EFNA5-6	chr5:106318191-106318244	NONHSAT103109
2	lnc-EFNA5-6	chr5:106320260-106321329	NONHSAT103109
3	lnc-EFNA5-5	chr5:106318910-106319012	NONHSAT103110
4	lnc-EFNA5-5	chr5:106319129-106319282	NONHSAT103110
5	lnc-EFNA5-2	chr5:106316465-106316570	XLOC_004951

No data

Variant related genes	Relation type
ENSG00000251027	TF binding region
ENSG00000251027	CpG island
BCL2L11	miRNA target sites

Extended variants
information (count: 663 )
Associated
traits (count: 79 )

Variant overlapped rSNPs/rCNVs (count:663 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4245987	chr5:106311248-106311249	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs75993313	chr5:106311252-106311253	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs539120190	chr5:106311255-106311256	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs558812983	chr5:106311267-106311268	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs576969304	chr5:106311288-106311289	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs544295712	chr5:106311298-106311299	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs555271660	chr5:106311302-106311303	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs543588229	chr5:106311313-106311314	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs193166225	chr5:106311342-106311343	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs144737442	chr5:106311348-106311349	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs565358682	chr5:106311364-106311365	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs540787502	chr5:106311375-106311376	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs184364457	chr5:106311407-106311408	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs370521297	chr5:106311456-106311457	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs142519092	chr5:106311484-106311485	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs545859295	chr5:106311492-106311493	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs189053326	chr5:106311561-106311562	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs531310945	chr5:106311565-106311566	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs547881957	chr5:106311596-106311597	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs567974479	chr5:106311622-106311623	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs374155602	chr5:106311674-106311675	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs192641565	chr5:106311677-106311678	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs375732839	chr5:106311686-106311687	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs555032479	chr5:106311705-106311706	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs547334225	chr5:106311706-106311707	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs72784386	chr5:106311753-106311754	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs539289336	chr5:106311769-106311770	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs184838904	chr5:106311774-106311775	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs146601283	chr5:106311783-106311784	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs115420621	chr5:106311814-106311815	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs57340269	chr5:106311843-106311844	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs574924694	chr5:106311846-106311847	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs540922427	chr5:106311875-106311876	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs62378355	chr5:106311876-106311877	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs577335967	chr5:106311887-106311888	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs546105575	chr5:106311905-106311906	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs146346527	chr5:106311910-106311911	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs368112388	chr5:106311914-106311915	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs562558052	chr5:106311930-106311931	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs189559460	chr5:106311966-106311967	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs180761061	chr5:106311967-106311968	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs147895081	chr5:106312003-106312004	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs561345268	chr5:106312021-106312022	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs117358147	chr5:106312033-106312034	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs113281150	chr5:106312050-106312051	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs4957680	chr5:106312172-106312173	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs533122022	chr5:106312235-106312236	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs549712592	chr5:106312257-106312258	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs143632049	chr5:106312259-106312260	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs186618976	chr5:106312265-106312266	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:79)

Disease	PMID	Source
Metanephric adenoma	20802469	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Cancer	16751803	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Breast cancer	17393978	CNVD
Cancer	21359685	CNVD
Non-small cell lung cancer	21829676	CNVD
adenomatous polyposis	22470819	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Lung cancer	18438408	CNVD
Retinoblastoma	22278416	CNVD
Bipolar disorder	18458673	CNVD
Thyroid cancer	19087340	CNVD
Breast cancer	21785460	CNVD
Squamous cell cancer	20885788	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	22521361	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	17133270	CNVD
Acute myeloid leukemia	20729466	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Acute myeloid leukemia	21251322	CNVD
lymphocytic leukemia	21291569	CNVD
Colorectal cancer	16272173	CNVD
Prostate cancer	16573809	CNVD
Cancer	20164920	CNVD
Myelodysplastic syndrome	21251322	CNVD
abnormal development	18461090	CNVD
Colorectal cancer	16774939	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Multiple myeloma	17550852	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Ovarian cancer	21720365	CNVD
Neurocytoma	17123091	CNVD
Salivary gland tumor	18059337	CNVD
Breast cancer	21509527	CNVD
Breast cancer	16608533	CNVD
Myelofibrosis	22110671	CNVD
Lung cancer	16773561	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD

Chromatin state (count:125 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:106302400-106314200	Weak transcription	H9 Cell Line	embryonic stem cell
2	chr5:106304600-106313000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
3	chr5:106308000-106313600	Enhancers	ES-I3 Cell Line	embryonic stem cell
4	chr5:106308200-106312000	Enhancers	HUES48 Cell Line	embryonic stem cell
5	chr5:106308400-106312200	Enhancers	HUES6 Cell Line	embryonic stem cell
6	chr5:106308400-106313200	Enhancers	HUES64 Cell Line	embryonic stem cell
7	chr5:106308800-106314200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
8	chr5:106309400-106313200	Enhancers	iPS-15b Cell Line	embryonic stem cell
9	chr5:106309800-106313200	Weak transcription	Colon Smooth Muscle	Colon
10	chr5:106310400-106311800	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
11	chr5:106310600-106311400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
12	chr5:106310600-106312000	Weak transcription	iPS-20b Cell Line	embryonic stem cell
13	chr5:106310600-106312200	Weak transcription	H1 Cell Line	embryonic stem cell
14	chr5:106311200-106313200	Enhancers	iPS-18 Cell Line	embryonic stem cell
15	chr5:106311400-106312000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
16	chr5:106311800-106312000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
17	chr5:106312000-106312200	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
18	chr5:106312000-106312400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
19	chr5:106312000-106312600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
20	chr5:106312000-106313000	Enhancers	iPS-20b Cell Line	embryonic stem cell
21	chr5:106312200-106312400	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
22	chr5:106312200-106312600	Enhancers	HUES48 Cell Line	embryonic stem cell
23	chr5:106312200-106314000	Enhancers	H1 Cell Line	embryonic stem cell
24	chr5:106312400-106312800	Enhancers	HUES6 Cell Line	embryonic stem cell
25	chr5:106312400-106313800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
26	chr5:106312600-106314400	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
27	chr5:106312600-106314400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
28	chr5:106312800-106314200	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
29	chr5:106313000-106313200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
30	chr5:106313000-106314000	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
31	chr5:106313200-106313800	Enhancers	Colon Smooth Muscle	Colon
32	chr5:106313200-106314000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
33	chr5:106313200-106314200	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
34	chr5:106313200-106314400	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
35	chr5:106313200-106314400	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
36	chr5:106313600-106313800	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
37	chr5:106313800-106314800	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
38	chr5:106313800-106320000	Active TSS	ES-I3 Cell Line	embryonic stem cell
39	chr5:106314000-106314200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
40	chr5:106314000-106314400	Flanking Active TSS	H1 Cell Line	embryonic stem cell
41	chr5:106314000-106316800	Active TSS	iPS-20b Cell Line	embryonic stem cell
42	chr5:106314200-106315200	Active TSS	HUES6 Cell Line	embryonic stem cell
43	chr5:106314200-106318200	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
44	chr5:106314200-106319800	Active TSS	iPS-15b Cell Line	embryonic stem cell
45	chr5:106314200-106320200	Active TSS	H9 Cell Line	embryonic stem cell
46	chr5:106314400-106314600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
47	chr5:106314400-106317800	Active TSS	HUES64 Cell Line	embryonic stem cell
48	chr5:106314400-106318000	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
49	chr5:106314400-106319000	Active TSS	iPS-18 Cell Line	embryonic stem cell
50	chr5:106314400-106319800	Active TSS	H1 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links